HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Senji Kasahara Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

4/2015[A female chronic myeloid leukemia patient who gave birth after stopping imatinib intentionally but who maintained a major molecular response with interferon].
6/2011Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Senji Kasahara Research Topics

Disease

13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2018 - 06/2006
9Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2023 - 06/2002
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023 - 08/2007
6Neoplasms (Cancer)
11/2023 - 02/2005
5Lymphoma (Lymphomas)
11/2023 - 06/2006
5Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 03/2008
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 08/2003
4Febrile Neutropenia
06/2023 - 06/2008
4Multiple Myeloma
06/2023 - 01/2010
4Thrombocytopenia (Thrombopenia)
02/2022 - 10/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2012
3Cardiotoxicity
10/2018 - 02/2004
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2017 - 01/2009
3Leukemia
01/2010 - 06/2009
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2022 - 12/2015
2Neutropenia
02/2022 - 12/2005
2Bronchiolitis Obliterans Syndrome
12/2021 - 01/2021
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021 - 06/2009
2Stomatitis
01/2021 - 12/2014
2Renal Insufficiency (Renal Failure)
01/2019 - 10/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2015 - 06/2011
2Primary Myelofibrosis (Myelosclerosis)
01/2011 - 08/2003
2Fever (Fevers)
11/2010 - 12/2005
1Hypotension (Low Blood Pressure)
11/2023
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2023
1Lymphadenopathy
09/2023
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2022
1acquired Thrombotic thrombocytopenic purpura
01/2019
1Thrombotic Thrombocytopenic Purpura
01/2019
1Hemolytic Anemia
01/2019
1Hemorrhage
01/2019
1Jaundice (Icterus)
11/2016
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2014
1Pain (Aches)
12/2014
1Aspiration Pneumonia
03/2013
1Blast Crisis (Blast Phase)
06/2011
1Philadelphia Chromosome
06/2011

Drug/Important Bio-Agent (IBA)

15Rituximab (Mabthera)FDA Link
11/2023 - 10/2009
14Prednisolone (Predate)FDA LinkGeneric
10/2018 - 06/2002
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018 - 06/2002
13Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 06/2002
11Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 02/2004
6pirarubicinIBA
10/2018 - 02/2004
4Etoposide (VP 16)FDA LinkGeneric
09/2017 - 06/2002
3Carboplatin (JM8)FDA LinkGeneric
11/2023 - 06/2002
3Cytarabine (Cytosar-U)FDA LinkGeneric
02/2022 - 08/2007
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2022 - 12/2005
3Interleukin-2 Receptors (IL 2 Receptor)IBA
05/2012 - 02/2005
2Azacitidine (5 Azacytidine)FDA Link
02/2024 - 01/2023
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2023 - 10/2022
2Melphalan (Alkeran)FDA LinkGeneric
06/2023 - 01/2010
2Lenalidomide (CC 5013)FDA Link
10/2022 - 12/2015
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2010
2polaprezinc (Z 103)IBA
01/2021 - 12/2014
2Proteins (Proteins, Gene)FDA Link
10/2020 - 06/2006
2IfosfamideFDA LinkGeneric
09/2017 - 06/2002
2Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 06/2002
2MethylprednisoloneFDA LinkGeneric
09/2017 - 08/2003
2Anti-Bacterial Agents (Antibiotics)IBA
12/2015 - 03/2013
2Type II Tumor Necrosis Factor ReceptorsIBA
10/2013 - 09/2006
1GemcitabineFDA Link
11/2023
1AcidsIBA
11/2023
1Protein Subunit VaccinesIBA
08/2023
1Peptides (Polypeptides)IBA
08/2023
1milademetanIBA
01/2023
1Bortezomib (Velcade)FDA Link
10/2022
1Bendamustine HydrochlorideFDA Link
02/2022
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2021
1thiamine triphosphorate (TTP)IBA
01/2019
1SteroidsIBA
01/2019
1AnthracyclinesIBA
06/2017
12- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA
06/2017
1InterleukinsIBA
12/2015
1Interleukin-8 (Interleukin 8)IBA
12/2015
1CytokinesIBA
12/2015
1Interleukin-1 (Interleukin 1)IBA
12/2015
1Interleukin-4 (Interleukin 4)IBA
12/2015
1Imatinib Mesylate (Gleevec)FDA Link
04/2015
1InterferonsIBA
04/2015
1Analgesics (Analgesic Drugs)IBA
12/2014
1SuspensionsIBA
12/2014
1azuleneIBA
12/2014
1AlginatesIBA
12/2014
1Interleukin-18 (Interleukin 18)IBA
09/2011
1Prednisone (Sone)FDA LinkGeneric
04/2011

Therapy/Procedure

17Therapeutics
06/2023 - 06/2002
10Drug Therapy (Chemotherapy)
11/2023 - 06/2002
5Transplantation
01/2021 - 03/2008
4VAP-cyclo protocol
06/2017 - 02/2004
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2021 - 01/2010
3Hematopoietic Stem Cell Transplantation
01/2021 - 06/2009
2Platelet Transfusion (Blood Platelet Transfusions)
02/2022 - 10/2009
2Radiotherapy
11/2016 - 12/2014
2Aftercare (After-Treatment)
03/2013 - 10/2009
1Punctures
09/2023
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021
1Plasma Exchange
01/2019
1Chemoradiotherapy
12/2014
1Induction Chemotherapy
06/2011